Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

@article{Owens2001SecondgenerationSH,
  title={Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine},
  author={M. Owens and D. Knight and C. Nemeroff},
  journal={Biological Psychiatry},
  year={2001},
  volume={50},
  pages={345-350}
}
  • M. Owens, D. Knight, C. Nemeroff
  • Published 2001
  • Chemistry, Medicine
  • Biological Psychiatry
    • BACKGROUND Single isomers of the selective serotonin reuptake inhibitors citalopram (escitalopram, S-citalopram) and fluoxetine (R-fluoxetine) are currently under development for the treatment of depression and other psychiatric disorders. Previous studies conducted in laboratory animals have revealed that the biological effects on serotonin reuptake for citalopram reside in the S enantiomer. In contrast, both enantiomers of fluoxetine contribute to its biological activity. METHODS In the… CONTINUE READING
    View on Elsevier
    doi.org
    320 Citations
    Highly Influencial Citations
    11
    Background Citations
    75
    Methods Citations
    11
    Results Citations
    5
    320 Citations
    Citation Type

    Citation Type

    [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    • 3
    • PDF
    PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.
    • 43
    • PDF
    Escitalopram: a second-generation SSRI.
    • 22
    The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse
    • 17
    Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram.
    • 22
    Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity
    • 149
    The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors
    • 129
    Managing depressive and anxiety disorders with escitalopram
    • M. Thase
    • Medicine
    • Expert opinion on pharmacotherapy
    • 2006
    • 29
    • Highly Influenced
    Investigating the Potential Role of Serotonin-2B Receptor Antagonism in the Neuronal Actions of Adjunctive Aripiprazole
    • PDF
    R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram
    • 56

    References

    SHOWING 1-10 OF 12 REFERENCES
    Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
    • 772
    Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors.
    • 96
    Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.
    • 599
    • PDF
    Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo
    • 74
    Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor.
    • 135
    Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.
    • 375
    Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac).
    • Y. G. Ni, R. Miledi
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 1997
    • 161
    • PDF
    Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450.
    • 134
    Analysis of Enantiomers of Citalopram and Its Demethylated Metabolites in Plasma of Depressive Patients Using Chiral Reverse‐Phase Liquid Chromatography
    • 112
    Plasma levels of citalopram enantiomers and metabolites in elderly patients.
    • 70